Effects of SGLT2 inhibitor dapagliflozin in a non-diabetic hypertensive model of heart failure with preserved ejection fraction

20 April 2018 (00:00 - 00:00)
Organised by: Logo
Congress Presentation Part of: LBS Poster Session 2 Heart Failure Open Access Frontiers in CardioVascular Biology 2018 Council on Basic Cardiovascular Science

ESC 365 is supported by

ESC 365 is supported by